Everstone invests in India's Translumina
The Everstone Group has invested in Translumina Therapeutics, a global manufacturer of medical devices based in India.
The size of Everstone’s commitment has not been disclosed, though Indian media reported that the GP paid INR5 billion ($69.7 million) for a significant minority stake. The investment is aimed at helping...
More on South Asia
Latest News
Q&A: Pomona Capital's Michael Granoff
Michael Granoff, founder and CEO of Pomona Capital, discusses raising capital from Asian LPs, how GPs can be differentiated in a crowded secondaries market, and why he’s not keen on fund restructurings
Japan's Tokio Marine Capital spins out from parent
Japanese mid-market buyout firm Tokio Marine Capital is spinning out from its corporate parent to form an independent investment manager known as T Capital Partners.
PE consortium makes $4.6b take-private bid for China Biologic
Centurium Capital, CITIC Capital and Hillhouse Capital are part of an investor group targeting a $4.6 billion take-private of China Biologic – just over a year after committing new equity to the US-listed company to protect it from other would-be acquirers.
Indian fintech player Groww raises $21m
Groww, an Indian financial technology provider focused on mutual fund investment services, has raised a $21.4 million Series B round led by US-based Ribbit Capital.